Global private equity firm General Atlantic is investing $55 million in the first round to acquire a minority stake in Indonesia-based Kalbe Genexine Biologics (KGBio), according to a press statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
